Certain Common Stock of TScan Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 25-AUG-2023. These Common Stock will be under lockup for 91 days starting from 26-MAY-2023 to 25-AUG-2023.

Details:
The Company directors, executive officers and certain of affiliated stockholders have entered into lock-up agreements for a period of 90 days after the date of the prospectus, offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend or otherwise transfer or dispose of, directly or indirectly, any shares of common stock or non-voting common stock or any securities convertible into or exercisable or exchangeable for shares of common stock or non-voting common stock;The lock-up agreements are subject to various exceptions, and directors and executive officers may be released from the lock-up agreements prior to the expiration of the lock-up period at the sole discretion of Morgan Stanley & Co. LLC.